Authors
Loading...
Investigation reveals EP300 regulates enhancer activity and promotes apoptosis in multiple myeloma, suggesting its therapeutic potential.
Talluri et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: